Interestingly, the radiological assessment showed that the use of cationic liposome-mediated interferon-beta (IFN-β) gene transfer treatment was able to induce a 50% tumor reduction in two out of five patients included in a pilot clinical trial [117]. Here, IFNB1 is linked to neoplasm.